Delfi Diagnostics (Series A)

Funding Details
Awarder
Inbox
Date Award
January 12, 2021
Vertical
Healthcare
Funding URL
View Funding Page
Funding Amount:
$100,000,000

Company Info
Founding Year
2019
Founders
Victor Velculescu
Company Description
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Market
Cancer Detection
Location
Baltimore, MD, USA
Coinvestors
AV8 Ventures, Cowen Healthcare Investments, Foresite Capital, Illumina Ventures, Menlo Ventures, Northpond Ventures, OrbiMed Advisors, Rock Springs Capital, Samsara BioCapital, T. Rowe Price Associates

Links